Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Other Accumulated Expenses (2015 - 2018)

Argenx Se's (ARGX) quarterly Other Accumulated Expenses came in at $29676.3 in Q4 2018, up 180.05% on a YoY basis from $10596.9 in Q4 2017, and up 180.05% quarter-over-quarter from $10596.9 in Q4 2017.

Analysis

Argenx Se (ARGX) Other Accumulated Expenses (2015 - 2018) Analysis & Trends

Argenx Se (ARGX) has reported Other Accumulated Expenses for 4 consecutive years, with $29676.3 the latest figure, recorded in Q4 2018.

  • For the quarter ending Q4 2018, Other Accumulated Expenses rose 180.05% year-over-year to $29676.3; the trailing twelve-month figure through Dec 2018 stood at $29676.3 (up 180.05% YoY), and the FY2018 full-year result was $29676.3, up 191.98% from the prior year.
  • Other Accumulated Expenses advanced to $29676.3 in Q4 2018 per ARGX's latest filing, from $10596.9 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $29676.3 in Q4 2018 and bottomed at $5480.6 in Q4 2015.
  • Historically, Other Accumulated Expenses has averaged $17376.9 across 4 years, with a median of $17175.4 in 2016.
  • The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses surged 333.42% in 2016, then plunged 55.39% in 2017.
  • Over 4 years, Other Accumulated Expenses stood at $5480.6 in 2015, then surged by 333.42% to $23753.9 in 2016, then slumped by 55.39% to $10596.9 in 2017, then jumped by 180.05% to $29676.3 in 2018.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $29676.3, $10596.9, and $23753.9 for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 29,676.31
Dec 31, 2017 10,596.89
Dec 31, 2016 23,753.93
Dec 31, 2015 5,480.59